Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
Drug Development & Rare Pediatric Diseases : Issues, Strategic Plan, & Voucher Program Assessment, Paperback / softback Book

Drug Development & Rare Pediatric Diseases : Issues, Strategic Plan, & Voucher Program Assessment Paperback / softback

Edited by Frederick Charles Johnston

Paperback / softback

Item not Available

Description

Over the past few decades, a number of legislative actions have been taken to encourage the development of therapies to treat people affected by rare diseases and to encourage therapies for pediatric patients.

During this same time period, the Food and Drug Administration (FDA) has invested substantial effort in support of these same goals.

As described in this book, recent legislative actions have prompted new initiatives.

Continuing the response to the laws specific requirements and FDAs commitment under PDUFA, this book includes input from the public and FDA and discusses the many complex issues involved in medical product development for people with rare diseases.

Following a brief overview of both legislative and FDA efforts over the years to foster development of therapies for these patients, the book summarizes the three days of the public meeting and presents FDAs strategic plan for accelerating the development of the urgently needed therapies for pediatric rare diseases.

Information

Save 23%

£52.99

£40.39

Item not Available
Item not Available
Sign in to add to wishlist
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information